What does this research mean for the field?

Elevated fasting glucose levels and hypoglycemia (particularly in adults under 65) are associated with an increased risk of cardiovascular disease mortality among cancer survivors. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

November 6, 2023CardioMetabolic Syndrome Journal4 citationsOpen Access

Associations Between Fasting Glucose and Cardiovascular Disease Mortality in Cancer Survivors: A Population-based Cohort Study

View Full Paper

Ask AI

Bookmark

Why the study?

Does abnormal fasting glucose level increase cardiovascular disease mortality in cancer survivors?

Population

177,774 cancer survivors, mean age 60.7 years, 57.8% female, from the Korea National Health Insurance…

Comparison

Abnormal fasting glucose levels categorized into… vs Normal fasting glucose level of 70-99 mg/dL.

Design

Cohort

Follow-up

Until December 2018 (from index date January 1, 2011)

Authors

MJMi‐Hyang Jung SYSang‐Wook Yi SASang Joon An

Discussion

Member takes

Overview

Abnormal fasting glucose was associated with higher CVD mortality in cancer survivors; hypothesis-generating and requires prospective trials before changing cardio-oncology practice.

Structured PICO

Does abnormal fasting glucose level increase cardiovascular disease mortality in cancer survivors?

Population

177,774 cancer survivors (diagnosed 2002-2005, survived >5 years as of December 31, 2010), mean age 60.7 years, 57.8% female, from the Korea National Health Insurance database. Excluded: known CVD at the time of health examination.

Intervention

Abnormal fasting glucose levels categorized into groups: <70 mg/dL, 100-125 mg/dL, 126-179 mg/dL, and ≥180 mg/dL.

Comparator

Normal fasting glucose level of 70-99 mg/dL.

Outcome

Death from overall cardiovascular disease (ICD codes I00-I99) followed until December 2018.hard clinical

Both hyperglycemia (≥126 mg/dL) and hypoglycemia (<70 mg/dL, particularly in younger adults) are associated with increased cardiovascular mortality in cancer survivors, emphasizing the importance of glycemic control in cardio-oncology survivorship care.

Cite This Study

Jung et al. (2023) studied this question.

synapsesocial.com/papers/6a255ee75ae39ea6a14898ba https://doi.org/10.51789/cmsj.2024.4.e1

View Full Paper

Ask AI

Bookmark

November 6, 2023CardioMetabolic Syndrome Journal4 citationsOpen Access

Associations Between Fasting Glucose and Cardiovascular Disease Mortality in Cancer Survivors: A Population-based Cohort Study

View Full Paper

Ask AI

Bookmark

Why the study?

Does abnormal fasting glucose level increase cardiovascular disease mortality in cancer survivors?

Population

177,774 cancer survivors, mean age 60.7 years, 57.8% female, from the Korea National Health Insurance…

Comparison

Abnormal fasting glucose levels categorized into… vs Normal fasting glucose level of 70-99 mg/dL.

Design

Cohort

Follow-up

Until December 2018 (from index date January 1, 2011)

Authors

MJMi‐Hyang Jung SYSang‐Wook Yi SASang Joon An

Discussion

Member takes

Overview

Abnormal fasting glucose was associated with higher CVD mortality in cancer survivors; hypothesis-generating and requires prospective trials before changing cardio-oncology practice.

Structured PICO

Does abnormal fasting glucose level increase cardiovascular disease mortality in cancer survivors?

Population

Intervention

Abnormal fasting glucose levels categorized into groups: <70 mg/dL, 100-125 mg/dL, 126-179 mg/dL, and ≥180 mg/dL.

Comparator

Normal fasting glucose level of 70-99 mg/dL.

Outcome

Death from overall cardiovascular disease (ICD codes I00-I99) followed until December 2018.hard clinical

Cite This Study

Jung et al. (2023) studied this question.

synapsesocial.com/papers/6a255ee75ae39ea6a14898ba https://doi.org/10.51789/cmsj.2024.4.e1

View Full Paper

Ask AI

Bookmark